ATE505486T1 - Rezeptor für das menschliche follikel- stimulierende hormon - Google Patents

Rezeptor für das menschliche follikel- stimulierende hormon

Info

Publication number: ATE505486T1
Authority: AT; Austria
Prior art keywords: receptor; mutant; fragment; fsh; present
Prior art date: 1991-03-15

Application number

AT01202809T

Other languages

English (en)

Inventor

Christie Ann Kelton

Shirley Vui Yen Cheng

Noreen Patrice Nugent

Rene Lynn Schweickhardt

Original Assignee

Merck Serono Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-15

Filing date

1992-01-02

Publication date

2011-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24688922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE505486(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-01-02 Application filed by Merck Serono Sa filed Critical Merck Serono Sa

2011-04-15 Application granted granted Critical

2011-04-15 Publication of ATE505486T1 publication Critical patent/ATE505486T1/de

Links

239000012634 fragment Substances 0.000 abstract 5
102000005962 receptors Human genes 0.000 abstract 5
108020003175 receptors Proteins 0.000 abstract 5
102000003864 Human Follicle Stimulating Hormone Human genes 0.000 abstract 2
108010082302 Human Follicle Stimulating Hormone Proteins 0.000 abstract 2
239000013604 expression vector Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
238000003556 assay Methods 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Immunology (AREA)
Cell Biology (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Steroid Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Materials For Medical Uses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01202809T 1991-03-15 1992-01-02 Rezeptor für das menschliche follikel- stimulierende hormon ATE505486T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US67008591A	1991-03-15	1991-03-15

Publications (1)

Publication Number	Publication Date
ATE505486T1 true ATE505486T1 (de)	2011-04-15

Family

ID=24688922

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT01202809T ATE505486T1 (de)	1991-03-15	1992-01-02	Rezeptor für das menschliche follikel- stimulierende hormon
AT92904833T ATE224446T1 (de)	1991-03-15	1992-01-02	Menschlicher rezeptor für das follikel- stimulierendes hormon.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT92904833T ATE224446T1 (de)	1991-03-15	1992-01-02	Menschlicher rezeptor für das follikel- stimulierendes hormon.

Country Status (19)

Country	Link
US (3)	US6372711B1 (de)
EP (2)	EP1167385B1 (de)
JP (1)	JP3581148B2 (de)
KR (1)	KR100245250B1 (de)
AT (2)	ATE505486T1 (de)
AU (1)	AU671417B2 (de)
CA (1)	CA2106061C (de)
DE (2)	DE69233805D1 (de)
DK (1)	DK0575357T3 (de)
ES (1)	ES2183806T3 (de)
FI (1)	FI109360B (de)
GE (1)	GEP19991604B (de)
LT (1)	LT3973B (de)
LV (1)	LV10724B (de)
MX (1)	MX9203350A (de)
NO (1)	NO315517B1 (de)
RU (1)	RU2193599C2 (de)
UA (1)	UA43826C2 (de)
WO (1)	WO1992016620A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993020199A1 (en) *	1992-03-30	1993-10-14	Akzo Nobel N.V.	Human gonadotropin receptor (fsh receptor)
EP1541689B1 (de)	1996-02-20	2012-09-05	Merck Serono SA	Heterodimerebildende Hybrid-Proteine
AU2728297A (en) *	1996-04-15	1997-11-07	Board Of Trustees Of The Leland Stanford Junior University	Soluble 7-transmembrane domain G-protein-coupled receptor compositions and me thods
US6521641B1 (en) *	1998-10-08	2003-02-18	Allergan, Inc.	Male anti-fertility agents
WO2000073416A1 (en) *	1999-05-28	2000-12-07	University Of Cincinnati	Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
WO2001088127A2 (en) *	2000-05-18	2001-11-22	Bayer Aktiengesellschaft	Regulation of human follicle stimulating hormone-like g protein-coupled receptor
US20030175889A1 (en) *	2002-01-23	2003-09-18	Arena Pharmaceuticals, Inc.	Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR
EP1466620A1 (de) *	2003-04-11	2004-10-13	AXXAM S.r.l.	Modulatoren des Follikel-stimulierenden Hormon-Rezeptors und ihre therapeutische Verwendung
US20100061976A1 (en) *	2008-07-24	2010-03-11	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4652450A (en) *	1984-08-31	1987-03-24	Research Corporation	Bacterial FSH binding inhibitor
US4761371A (en)	1985-02-12	1988-08-02	Genentech, Inc.	Insulin receptor
US4859609A (en) *	1986-04-30	1989-08-22	Genentech, Inc.	Novel receptors for efficient determination of ligands and their antagonists or agonists
US4921808A (en) *	1986-06-25	1990-05-01	The Albany Medical College Of Union University	Method for determining follicle stimulating hormone
US4960700A (en) *	1986-12-24	1990-10-02	Genentech, Inc.	Compositions and methods for the synthesis and assay of a mammalian enkephalinase
DE69033990T2 (de) *	1989-05-05	2003-02-13	Genentech, Inc.	Glykoprotein-Hormonrezeptor-Moleküle
US5155218A (en) *	1990-05-08	1992-10-13	Neurogenetic Corporation	Dna encoding human 5-ht1d receptors

1992
- 1992-01-02 AU AU12514/92A patent/AU671417B2/en not_active Expired
- 1992-01-02 DK DK92904833T patent/DK0575357T3/da active
- 1992-01-02 CA CA002106061A patent/CA2106061C/en not_active Expired - Lifetime
- 1992-01-02 ES ES92904833T patent/ES2183806T3/es not_active Expired - Lifetime
- 1992-01-02 JP JP50530292A patent/JP3581148B2/ja not_active Expired - Lifetime
- 1992-01-02 AT AT01202809T patent/ATE505486T1/de not_active IP Right Cessation
- 1992-01-02 WO PCT/US1992/000122 patent/WO1992016620A1/en not_active Ceased
- 1992-01-02 AT AT92904833T patent/ATE224446T1/de not_active IP Right Cessation
- 1992-01-02 RU RU93057956/13A patent/RU2193599C2/ru active
- 1992-01-02 EP EP01202809A patent/EP1167385B1/de not_active Expired - Lifetime
- 1992-01-02 EP EP92904833A patent/EP0575357B1/de not_active Expired - Lifetime
- 1992-01-02 GE GEAP19921579A patent/GEP19991604B/en unknown
- 1992-01-02 DE DE69233805T patent/DE69233805D1/de not_active Expired - Lifetime
- 1992-01-02 DE DE69232779T patent/DE69232779T2/de not_active Expired - Lifetime
- 1992-02-01 UA UA93004376A patent/UA43826C2/uk unknown
- 1992-06-25 MX MX9203350A patent/MX9203350A/es unknown
1993
- 1993-09-14 NO NO19933272A patent/NO315517B1/no not_active IP Right Cessation
- 1993-09-14 FI FI934023A patent/FI109360B/fi active
- 1993-09-15 KR KR1019930702771A patent/KR100245250B1/ko not_active Expired - Lifetime
- 1993-10-11 LV LVP-93-1136A patent/LV10724B/en unknown
- 1993-12-20 LT LTIP1631A patent/LT3973B/lt not_active IP Right Cessation
1995
- 1995-06-07 US US08/474,986 patent/US6372711B1/en not_active Expired - Lifetime
- 1995-06-07 US US08/487,886 patent/US5744448A/en not_active Expired - Lifetime
- 1995-06-07 US US08/482,855 patent/US6121016A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US6121016A (en)	2000-09-19
DE69232779D1 (de)	2002-10-24
ATE224446T1 (de)	2002-10-15
EP0575357A1 (de)	1993-12-29
GEP19991604B (en)	1999-04-29
WO1992016620A1 (en)	1992-10-01
UA43826C2 (uk)	2002-01-15
EP0575357B1 (de)	2002-09-18
NO933272L (no)	1993-09-14
FI934023A0 (fi)	1993-09-14
JP3581148B2 (ja)	2004-10-27
CA2106061A1 (en)	1992-09-16
DE69232779T2 (de)	2003-01-30
AU671417B2 (en)	1996-08-29
AU1251492A (en)	1992-10-21
DE69233805D1 (de)	2011-05-26
CA2106061C (en)	2008-10-07
LTIP1631A (en)	1995-07-25
LT3973B (en)	1996-05-27
NO315517B1 (no)	2003-09-15
MX9203350A (es)	1992-08-01
US5744448A (en)	1998-04-28
RU2193599C2 (ru)	2002-11-27
EP1167385B1 (de)	2011-04-13
EP1167385A2 (de)	2002-01-02
FI934023L (fi)	1993-09-14
US6372711B1 (en)	2002-04-16
JPH06505157A (ja)	1994-06-16
KR100245250B1 (en)	2000-02-15
LV10724B (en)	1995-12-20
DK0575357T3 (da)	2002-11-25
ES2183806T3 (es)	2003-04-01
EP1167385A3 (de)	2003-04-16
LV10724A (lv)	1995-06-20
FI109360B (fi)	2002-07-15
NO933272D0 (no)	1993-09-14

Legal Events

Date

Code

Title

Description

2011-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1167385

Country of ref document: EP

2012-04-15

EELA

Cancelled due to lapse of time

Publication	Publication Date	Title
SE8603966D0 (sv)	1986-09-19	Fluoroaluminosilicate glass powder for dental glass ionomer cement
ATE464067T1 (de)	2010-04-15	Bindegewebs wachstumsfaktor (ctgf)
EP0690915A4 (de)	1997-11-12	Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung
DE68927073D1 (de)	1996-10-10	Modifiziertes Baculovirus,Herstellung und Verwendung als Expressionsvektor
ES2098271T3 (es)	1997-05-01	Factor neurotrofico derivado del cerebro.
BR1101088A (pt)	2002-04-02	Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
WO1997026277A3 (en)	1997-09-25	Morphogen analogs and methods for producing them
ATE224446T1 (de)	2002-10-15	Menschlicher rezeptor für das follikel- stimulierendes hormon.
ATE269355T1 (de)	2004-07-15	Antigene, die von polyarthritis rheumatoide antikörpern erkannt werden, ihre herstellung und ihre anwendungen
EP1093457A4 (de)	2003-01-02	Der allgemeinen gamma-kette ähnlicher zytokinrezeptor
NO890008D0 (no)	1989-01-02	Forspent konstruksjonselement av sammensatt struktur og fremgangsmaate for fremstilling av dette.
ATE180275T1 (de)	1999-06-15	Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin
ATE258933T1 (de)	2004-02-15	Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
DE3751893D1 (de)	1996-10-10	Polypeptid und dessen Herstellung
DK0588118T3 (da)	2000-10-02	Carboxypeptidaselignende protein knyttet til knogler samt fremgangsmåde til fremstilling deraf
DE69015175D1 (de)	1995-01-26	Glykoprotein-hormonrezeptor-moleküle.
RU93057956A (ru)	1996-07-10	Рецептор, днк, вектор, клетка, способ получения рецептора, фармацевтическая композиция, способы анализа, способ снижения биоактивности, способы предупреждения спермадогенеза и созревания фолликулов
WO2003052377A9 (en)	2013-10-24	41 human secreted proteins
DE3850933D1 (de)	1994-09-08	Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
ATE124722T1 (de)	1995-07-15	Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung.
IT1254705B (it)	1995-10-09	Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante